These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18389088)

  • 1. Retapamulin: a new topical antibiotic for the treatment of uncomplicated skin infections.
    Parish LC; Parish JL
    Drugs Today (Barc); 2008 Feb; 44(2):91-102. PubMed ID: 18389088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retapamulin: a review of its use in the management of impetigo and other uncomplicated superficial skin infections.
    Yang LP; Keam SJ
    Drugs; 2008; 68(6):855-73. PubMed ID: 18416589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spotlight on retapamulin in impetigo and other uncomplicated superficial skin infections.
    Yang LP; Keam SJ
    Am J Clin Dermatol; 2008; 9(6):411-3. PubMed ID: 18973410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: results of a randomized controlled trial.
    Parish LC; Jorizzo JL; Breton JJ; Hirman JW; Scangarella NE; Shawar RM; White SM;
    J Am Acad Dermatol; 2006 Dec; 55(6):1003-13. PubMed ID: 17097398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, comparative study to assess the safety and efficacy of topical retapamulin ointment 1% versus oral linezolid in the treatment of secondarily infected traumatic lesions and impetigo due to methicillin-resistant Staphylococcus aureus.
    Tanus T; Scangarella-Oman NE; Dalessandro M; Li G; Breton JJ; Tomayko JF
    Adv Skin Wound Care; 2014 Dec; 27(12):548-59. PubMed ID: 25396674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiological profile of a new topical antibacterial: retapamulin ointment 1%.
    Scangarella-Oman NE; Shawar RM; Bouchillon S; Hoban D
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):269-79. PubMed ID: 19344241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of retapamulin 1% ointment for the treatment of infected atopic dermatitis: a pilot study.
    Kircik LH
    J Drugs Dermatol; 2012 Jul; 11(7):858-60. PubMed ID: 22777229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retapamulin: a semisynthetic pleuromutilin compound for topical treatment of skin infections in adults and children.
    Jacobs MR
    Future Microbiol; 2007 Dec; 2(6):591-600. PubMed ID: 18041900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and efficacy of topical retapamulin ointment versus placebo ointment in the treatment of secondarily infected traumatic lesions: a randomized, double-blind superiority study.
    Tomayko JF; Li G; Breton JJ; Scangarella-Oman N; Dalessandro M; Martin M
    Adv Skin Wound Care; 2013 Mar; 26(3):113-21. PubMed ID: 23426412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retapamulin: what is the role of this topical antimicrobial in the treatment of bacterial infections in atopic dermatitis?
    Moody MN; Morrison LK; Tyring SK
    Skin Therapy Lett; 2010 Jan; 15(1):1-4. PubMed ID: 20066388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retapamulin ointment twice daily for 5 days vs oral cephalexin twice daily for 10 days for empiric treatment of secondarily infected traumatic lesions of the skin.
    Free A; Roth E; Dalessandro M; Hiram J; Scangarella N; Shawar R; White S;
    Skinmed; 2006; 5(5):224-32. PubMed ID: 16957433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial.
    Koning S; van der Wouden JC; Chosidow O; Twynholm M; Singh KP; Scangarella N; Oranje AP
    Br J Dermatol; 2008 May; 158(5):1077-82. PubMed ID: 18341664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity against anaerobes of retapamulin, a new topical antibiotic for treatment of skin infections.
    Odou MF; Muller C; Calvet L; Dubreuil L
    J Antimicrob Chemother; 2007 Apr; 59(4):646-51. PubMed ID: 17350985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retapamulin: a newer topical antibiotic.
    Dhingra D; Parakh A; Ramachandran S
    J Postgrad Med; 2013; 59(2):127-30. PubMed ID: 23793314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical retapamulin ointment, 1%, versus sodium fusidate ointment, 2%, for impetigo: a randomized, observer-blinded, noninferiority study.
    Oranje AP; Chosidow O; Sacchidanand S; Todd G; Singh K; Scangarella N; Shawar R; Twynholm M;
    Dermatology; 2007; 215(4):331-40. PubMed ID: 17911992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retapamulin: an antibacterial with a novel mode of action in an age of emerging resistance to Staphylococcus aureus.
    Weinberg JM; Tyring SK
    J Drugs Dermatol; 2010 Oct; 9(10):1198-204. PubMed ID: 20941943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retapamulin for impetigo and other infections.
    Drug Ther Bull; 2008 Oct; 46(10):76-9. PubMed ID: 18832258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retapamulin (Altabax)--a new topical antibiotic.
    Med Lett Drugs Ther; 2008 Feb; 50(1280):13-5. PubMed ID: 18292714
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical characterization of the interactions of the novel pleuromutilin derivative retapamulin with bacterial ribosomes.
    Yan K; Madden L; Choudhry AE; Voigt CS; Copeland RA; Gontarek RR
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3875-81. PubMed ID: 16940066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical retapamulin in the management of infected traumatic skin lesions.
    Shawar R; Scangarella-Oman N; Dalessandro M; Breton J; Twynholm M; Li G; Garges H
    Ther Clin Risk Manag; 2009 Feb; 5(1):41-9. PubMed ID: 19436611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.